Belgravia Dermatology Completes Identification of Initial Drug Targets Within the Skin Endocannabinoid System and Also Identifies Bio Markers for Pre Clinical Work in Acne
June 18, 2018 07:00 ET
|
Belgravia Capital International
TORONTO, June 18, 2018 (GLOBE NEWSWIRE) -- BELGRAVIA CAPITAL INTERNATIONAL INC. (CSE:BLGV) (OTCQB:BLGVF) (“Belgravia” or the “Company”) today announced that its subsidiary, Belgravia Dermatology...
BELGRAVIA CAPITAL completes acquisition of interest in R&D Pharma Corp., a Canadian corporation building a vertically integrated medical cannabis business in Jamaica
May 30, 2018 07:00 ET
|
Belgravia Capital International
TORONTO, May 30, 2018 (GLOBE NEWSWIRE) -- BELGRAVIA CAPITAL INTERNATIONAL INC. (CSE:BLGV) (OTCQB:BLGVF) (“Belgravia Capital”, “Belgravia”, or the “Company”) is pleased to announce that it has...
Belgravia Completes Transition of ICP Organics to Dermatology Product Development, Renames ICP Organics to Belgravia Dermatology Inc., and Appoints Sidney Himmel Director of Belgravia Dermatology
May 11, 2018 07:00 ET
|
Belgravia Capital International
TORONTO, May 11, 2018 (GLOBE NEWSWIRE) -- BELGRAVIA CAPITAL INTERNATIONAL INC. (CSE:BLGV) (OTCQB:BLGVF) (“Belgravia” or the “Company”) today announced that it has completed the strategic transition...
Belgravia Announces Results of Annual Meeting
April 27, 2018 07:00 ET
|
Belgravia Capital International
TORONTO, April 27, 2018 (GLOBE NEWSWIRE) -- Belgravia Capital International Inc. (CSE:BLGV) (OTCQB:BLGVF) (“Belgravia” or the “Company”) is pleased to announce the results of the Company’s Annual...
Belgravia Appoints Dr. Sam Hanna Chief Medical Officer of Cannabis Dermatology Division
April 18, 2018 07:00 ET
|
Belgravia Capital International
TORONTO, April 18, 2018 (GLOBE NEWSWIRE) -- BELGRAVIA CAPITAL INTERNATIONAL INC. (CSE:BLGV) (OTCQB:BLGVF) (“Belgravia” or the “Company”) has appointed Dr. Sam Hanna as Chief Medical Officer of its...
BELGRAVIA CAPITAL adds to expertise in corporate development and expands medical advisory committee
March 12, 2018 07:00 ET
|
Belgravia Capital International
TORONTO, March 12, 2018 (GLOBE NEWSWIRE) -- BELGRAVIA CAPITAL INTERNATIONAL INC. (CSE:BLGV) (OTCQB:BLGVF) (“Belgravia Capital”, “Belgravia”, or the “Company”) is pleased to announce senior additions...
BELGRAVIA CAPITAL INTERNATIONAL and Fanlogic Commence Design of Blockchain Loyalty Program for the Global Cannabis Industry
January 25, 2018 07:00 ET
|
Belgravia Capital International
TORONTO, Jan. 25, 2018 (GLOBE NEWSWIRE) -- BELGRAVIA CAPITAL INTERNATIONAL INC. (CSE:BLGV) (OTCQB:BLGVF) (“Belgravia Capital”, “Belgravia”, or the “Company”) is pleased to announce the execution of...
BELGRAVIA CAPITAL INTERNATIONAL receives cash payment, appoints renowned Dermatologist as special advisor to ICP Organics, and provides updates on additional blockchain developments
January 10, 2018 07:00 ET
|
Belgravia Capital International
TORONTO, Jan. 10, 2018 (GLOBE NEWSWIRE) -- BELGRAVIA CAPITAL INTERNATIONAL INC. (CSE:BLGV) (OTCQB:BLGVF) (“Belgravia Capital”, “Belgravia”, or the “Company”) is pleased to announced that the second...
BELGRAVIA CAPITAL INTERNATIONAL announces LOI with R&D Pharma Corp.
January 04, 2018 07:00 ET
|
Belgravia Capital International
TORONTO, Jan. 04, 2018 (GLOBE NEWSWIRE) -- BELGRAVIA CAPITAL INTERNATIONAL INC. (CSE:BLGV) (OTCQB:BLGVF) (“Belgravia Capital”, “Belgravia”, or the “Company”) is pleased to announce the execution of...
BELGRAVIA CAPITAL Corporate Update
December 05, 2017 09:03 ET
|
Belgravia Capital International
TORONTO, Dec. 05, 2017 (GLOBE NEWSWIRE) -- BELGRAVIA CAPITAL INTERNATIONAL INC. (CSE:BLGV) (OTCQB:BLGVF) (“Belgravia Capital”, or the “Company”) is pleased to comment on share price and trading...